Skip to main content
. 2021 Feb 25;12:571229. doi: 10.3389/fendo.2021.571229

Table 4.

Regression analysis on the effect of prolactin upon hormonal and metabolic outcomes in patients with PCOS.

Variables PRL Age BMI R R2 Adjusted R2
WC (cm) −0.001 2.349 2.537 0.217 0.047 0.029
HC (cm) −0.008 −0.325* 1.867** 0.777 0.603 0.596
Basal serum LH (nmol/L) −0.009** −0.168* −0.311** 0.261 0.068 0.065
LH/FSH −0.001** −0.025* −0.029** 0.216 0.047 0.043
E2 (pmol/L) −0.055* 1.245 −1.280 0.108 0.012 0.008
FINS (pmol/L) −0.066* −1.399 7.991** 0.334 0.112 0.108
HOMA-IR (log10) −0.102* −0.033 0.293** 0.210 0.044 0.041
HOMA-β −0.121* −2.877 11.709** 0.302 0.091 0.088
TG (mmol/L) 0.000 0.019 0.081** 0.319 0.102 0.098
HDL-C (mmol/L) 0.733 −0.007* −0.031** 0.413 0.170 0.167
ALT (U/L) −0.004 −0.046 1.819** 0.211 0.044 0.041

Multiple regression analyses were performed with metabolic and hormonal outcomes as dependent variables and prolactin, age, and BMI as explanatory variables.

Data are presented as B-values (P-levels): *P < 0.05, **P< 0.001.